Form Type: 4

SEC EDGAR Link
Accession Number:0001209191-20-008057
Date:2020-02-06
Issuer: AERIE PHARMACEUTICALS INC (AERI)
Original Submission Date:

Reporting Person:

KOPCZYNSKI CASEY C.
C/O AERIE PHARMACEUTICALS, INC.
4301 EMPEROR BLVD., SUITE 400 DURHAM, NC 27703

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
COMMON STOCK 2020-02-06 A 10,000 a $0.00 228,511 direct
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
STOCK OPTION (RIGHT TO BUY) 21.18 2020-02-06 deemed execution date A 45,000 (a) 2030-02-06 common stock 45,000 $21.18 45,000 direct
Footnotes
IDfootnote
f1 these shares of common stock are scheduled to vest, subject to the reporting person's continued employment with the issuer through the applicable vesting date, in equal installments on each of the first four anniversaries of february 6, 2020.
f2 this option is scheduled to vest, subject to the reporting person's continued employment with the issuer through the applicable vesting date, in equal installments on each of the first 48 monthly anniversaries of february 6, 2020.
WhaleWisdom Logo

Elevate your investments